文献速递儿童青少年精神心境障碍

辩证行为疗法对青少年双相障碍的随机临床试验

Dialectical Behavior Therapy for Adolescents With Bipolar Disorder: A Randomized Clinical Trial.
PubMed 文献 · JAMA Psychiatry · 2024-01-01

这项随机临床试验纳入100名12至18岁双相谱系障碍青少年,比较辩证行为疗法(DBT)与常规心理治疗(SOC)在1年内减少自杀企图的效果。结果显示DBT组自杀企图发生率显著低于SOC组(ALIFE IRR 0.32,C-SSRS IRR 0.13),且两组心境症状改善相似。DBT减少自杀企图的效果由情绪失调改善所中介。

要点

  • DBT组1年内自杀企图发生率显著低于SOC组(ALIFE IRR 0.32,C-SSRS IRR 0.13)。
  • 两组心境症状和发作在1年内均显著改善且程度相似。
  • DBT减少自杀企图的效果由情绪失调改善中介,尤其在高基线情绪失调者中。

核心结论

  • 在双相谱系障碍青少年中,DBT较SOC心理治疗更有效减少1年内自杀企图。

研究设计与样本

  • 随机临床试验,2014年11月至2019年9月从专科门诊精神科诊所招募12至18岁双相谱系障碍青少年。
  • 共纳入100名参与者,随机分配至1年DBT(36次,n=47)或SOC心理治疗(日程临床决定,n=53),所有青少年接受灵活算法的药物管理。
  • 独立评估者在1年内每季度对参与者和父母进行评估,平均随访47(SD 14)周。

主要发现

  • 两组心境症状和发作在1年内均显著且相似改善(标准化抑郁评定量表斜率-0.17,95%CI -0.31至-0.03;标准化躁狂评定量表斜率-0.24,95%CI -0.34至-0.14)。
  • DBT组随访期间自杀企图显著少于SOC组(ALIFE每随访期平均尝试次数0.2 vs 1.1,控制基线尝试P=0.03;C-SSRS 0.04 vs 0.10,P=0.03)。
  • DBT减少自杀企图的效果由终生自杀企图史和时间所调节(IRR 0.23,95%CI 0.13-0.44),并由情绪失调改善所中介(IRR 0.61,95%CI 0.42-0.89),尤其在高基线情绪失调者中(标准化β -0.59,95%CI -0.92至-0.26)。

关键数值与推荐

  • DBT vs SOC减少1年自杀企图:ALIFE IRR 0.32(95%CI 0.11-0.96);C-SSRS IRR 0.13(95%CI 0.02-0.78)。

临床怎么用

  • 对于双相谱系障碍青少年,DBT可作为减少自杀企图的心理社会干预选择,尤其适用于有终生自杀企图史或高基线情绪失调者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Early-onset bipolar disorder conveys substantial risk for suicide. No psychosocial intervention for this population expressly targets suicidal behavior. OBJECTIVE: To determine whether dialectical behavior therapy (DBT) for adolescents with bipolar spectrum disorder is more effective than standard of care (SOC) psychotherapy in decreasing suicide attempts over 1 year. DESIGN, SETTINGS, AND PARTICIPANTS: Adolescents aged 12 to 18 years diagnosed with bipolar spectrum disorder were recruited from a specialty outpatient psychiatric clinic between November 2014 and September 2019. Independent evaluators conducted quarterly assessments over 1 year with participants and parents. Data were analyzed from March 2021 to November 2022. INTERVENTIONS: Participants were randomly assigned to 1 year of DBT (36 sessions; n = 47) or SOC psychotherapy (schedule clinically determined; n = 53). All youth received medication management via a flexible algorithm. MAIN OUTCOMES AND MEASURES: Primary outcomes included suicide attempts over 1 year and mood symptoms and states (depression and hypomania/mania). Secondary analyses included moderation of DBT effects by history of suicide attempt and mediation through emotion dysregulation. RESULTS: Of 100 included participants, 85 (85%) were female, and the mean (SD) age was 16.1 (1.6) years. Participants were followed up over a mean (SD) of 47 (14) weeks. Both treatment groups demonstrated significant and similar improvement in mood symptoms and episodes over 1 year (standardized depression rating scale slope, -0.17; 95% CI, -0.31 to -0.03; standardized mania rating scale slope, -0.24; 95% CI, -0.34 to -0.14). DBT and SOC participants reported similar suicide attempt rates at intake as measured on the Adolescent Longitudinal Follow-Up Evaluation (ALIFE; mean [SD] attempts, 2.0 [4.5] vs 1.8 [3.9], respectively; P = .80). DBT participants reported slightly more suicide attempts at intake as measured on the Columbia-Suicide Severity Rating Scale Pediatric Version (C-SSRS; mean [SD] attempts, 1.4 [3.6] vs 0.6 [0.9]; P = .02). DBT participants reported significantly fewer suicide attempts over follow-up compared with SOC participants via the ALIFE (mean [SD] attempts per follow-up period, 0.2 [0.4] vs 1.1 [4.3], controlling for baseline attempts: P = .03) and the C-SSRS (mean [SD] attempts per follow-up period, 0.04 [0.2] vs 0.10 [0.3], controlling for baseline attempts; P = .03). DBT was significantly more effective than SOC psychotherapy at decreasing suicide attempts over 1 year (ALIFE: incidence rate ratio [IRR], 0.32; 95% CI, 0.11-0.96; C-SSRS: IRR, 0.13; 95% CI, 0.02-0.78). Decreased rate of suicide attempts in DBT was moderated by presence of lifetime history of suicide attempt and time (IRR, 0.23; 95% CI, 0.13-0.44) and mediated by improvement in emotion dysregulation (IRR, 0.61; 95% CI, 0.42-0.89), particularly for those with high baseline emotion dysregulation (standardized β, -0.59; 95% CI, -0.92 to -0.26). CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, DBT demonstrated efficacy in decreasing suicide attempts among the high-risk population of adolescents with bipolar spectrum disorder. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02003690.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Goldstein TR, Merranko J, Rode N, et al. Dialectical Behavior Therapy for Adolescents With Bipolar Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2024. PMID: 37703037. doi:10.1001/jamapsychiatry.2023.3399

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。